The FDA is warning a company that sells at-home DNA tests to stop selling the product. The company, 23andMe, acknowledged that the product hasn’t been approved by the FDA.The U.S. Food and Drug Administration sent a letter to 23andMe November 22, saying tests like the company sells are required to be approved, that’s according to a Reuters article.The company was founded in 2006 and has been backed by Google. 23andMe sells $99 at-home DNA tests that the company says can detect a range of genetic mutations and provide information about a person’s health risks.The FDA says the tests pose a risk for certain cancers, and if a false positive is given for breast or ovarian cancer, the FDA says it could lead to a patient undergoing preventative surgery, intensive screening or other risky procedures.23andMe released this statement: Our relationship with the FDA is extremely important to us and we are committed to fully engaging with them to address their concerns.23andMe has mapped the genotype of 475,000 people over the last five years.

source